Help me, Doctor! My D-dimer is raised

Annals of Medicine

Volumn 40, Issue 8, 2008, Pages 594-605

  Lippi, Giuseppe ^a,b   Franchini, Massimo ^b   Targher, Giovanni ^a   Favaloro, Emmanuel J ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Cancer; D dimer; Prognosis; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; BIOLOGICAL MARKER; D DIMER;

ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFECTION; NEOPLASM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; THROMBOSIS; VENOUS THROMBOEMBOLISM;

ALGORITHMS; ANIMALS; ANTICOAGULANTS; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; EDUCATION, MEDICAL; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; VENOUS THROMBOEMBOLISM;

EID: 56849128277     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890802161015     Document Type: Review

References (81)

1. Wakai A, Gleeson A, Winter D. Role of fibrin D-dimer testing in emergency medicine. Emerg Med J. 2003;20:319-25.
2. Conard J, Bauer KA, Gruber A, Griffin JH, Schwarz HP, Horellou MH, et al. Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency. Blood. 1993;82:1159-64.
3. Bockenstedt P. D-dimer in venous thromboembolism. N Engl J Med. 2003;349:1203-4.
4. Lippi G, Mengoni A, Manzato F. Plasma D-dimer in the diagnosis of deep vein thrombosis. JAMA. 1998;280:1828-9.
5. Kearon C, Ginsberg JS, Douketis J, Turpie AG, Bates SM, Lee AY, et al. Canadian Pulmonary Embolism Diagnosis Study (CANPEDS) Group. An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann Intern Med. 2006;144:812-21.
6. Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med. 2004;140:589-602.
7. Di Nisio M, Squizzato A, Rutjes AW, Büller HR, Zwinderman AH, Bossuyt PM. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost. 2007;5:296-304.
8. Qaseem A, Snow V, Barry P, Hornbake ER, Rodnick JE, Tobolic T, et al. Current diagnosis of venous thromboembolism in primary care: A clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med. 2007;146:454-8.
9. Institute for Clinical Systems Improvement. Health care guideline: venous thromboembolism. Revised February 2006. Available at: www.icsi.org (accessed on 24 December 2007).
10. Stein PD, Woodard PK, Weg JG, Wakefield TW, Tapson VF, Sostman HD, et al. PIOPED II Investigators. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. Radiology. 2007;242:15-21.
11. Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Perrier A, et al. Value of D-dimer testing for the exclusion of pulmonary embolism in patients with previous venous thromboembolism. Arch Intern Med. 2006;166:176-80.
12. Squizzato A, Ageno W. D-dimer testing in ischemic stroke and cerebral sinus and venous thrombosis. Semin Vasc Med. 2005;5:379-86.
13. Deng MH, Liu B, Fang HP, Pan WD, Tang ZF, Deng P, et al. Predictive value of D-dimer for portal vein thrombosis after portal hypertension surgery in hepatitis B virus-related cirrhosis. World J Gastroenterol. 2007;13:6588-92.
14. Stamou KM, Toutouzas KG, Kekis PB, Nakos S, Gafou A, Manouras A, et al. Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg. 2006;141:663-9.
15. Sajid MS, Ahmed N, Desai M, Baker D, Hamilton G. Upper limb deep vein thrombosis: A literature review to streamline the protocol for management. Acta Haematol. 2007;118:10-8.
16. Cavaliere G, Leanza A, Mirabella C, Rapisarda A, Meli S, Noto P, et al. Dangerous thrombophilic states and internal pathologies: 3 cases of thrombosis of the abdominal veins. Eur Rev Med Pharmacol Sci. 2001;5167-72.
17. Horan JT, Francis CW. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Semin Thromb Hemost. 2001;27:657-66.
18. Wada H, Sakuragawa N, Mori Y, Takagi M, Nakasaki T, Shimura M, et al. Hemostatic molecular markers before the onset of disseminated intravascular coagulation. Am J Hematol. 1999;60:273-8.
19. Toh CH, Hoots WK; SCC on Disseminated Intravascular Coagulation of the ISTH. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on thrombosis and haemostasis: a 5-year overview. J Thromb Haemost. 2007;5:604-6.
20. Levi M, de Jonge E, Meijers J. The diagnosis of disseminated intravascular coagulation. Blood Rev. 2002;16:217-23.
21. Lippi G, Filippozzi L, Montagnana M, Salvagno GL, Guidi GC. Diagnostic value of D-dimer measurement in patients referred to the emergency department with suspected myocardial ischemia. J Thromb Thrombolysis. 2007 Jun 1 (Epub ahead of print).
22. Ohlmann P, Faure A, Morel O, Petit H, Kabbaj H, Meyer N, et al. Diagnostic and prognostic value of circulating D-dimers in patients with acute aortic dissection. Crit Care Med. 2006;34:1358-64.
23. von Kanel R, Dimsdale JE, Adler KA, Patterson TL, Mills PJ, Grant I. Exaggerated plasma fibrin formation (D-dimer) in elderly Alzheimer caregivers as compared to noncaregiving controls. Gerontology. 2005;51:7-13.
24. Block T, Nilsson TK, Björck M, Acosta S. Diagnostic accuracy of plasma biomarkers for intestinal ischaemia. Scand J Clin Lab Invest. 2008;68:242-8.
25. Gladwin MT, Kato GJ. Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens! Haematologica. 2008;93:1-3.
26. Samama MM, Horellou MH, Elalamy I, Mathieux V, Ombandza-Moussa E, Conard J. D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implications. Semin Vasc Med. 2005;5:371-4.
27. Grau E, Tenías JM, Soto MJ, Gutierrez MR, Lecumberri R, Pérez JL, et al. RIETE Investigators. D-dimer levels correlate with mortality in patients with acute pulmonary embolism: Findings from the RIETE registry. Crit Care Med. 2007;35:1937-41.
28. Aujesky D, Roy PM, Guy M, Cornuz J, Sanchez O, Perrier A. Prognostic value of D-dimer in patients with pulmonary embolism. Thromb Haemost. 2006;96:478-82.
29. Paneesha S, Cheyne E, French K, Bacchu S, Borg A, Rose P. High D-dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes. Br J Haematol. 2006;135:85-90.
30. Klok FA, Djurabi RK, Nijkeuter M, Eikenboom HC, Leebeek FW, Kramer MH, et al. High D-dimer level is associated with increased 15-d and 3 months mortality through a more central localization of pulmonary emboli and serious comorbidity. Br J Haematol. 2008;140:218-22.
31. Palareti G, Legnani C, Cosmi B, Valdré L, Lunghi B, Bernardi F, et al. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation. 2003;108:313-8.
32. Goldenberg NA. Long-term outcomes of venous thrombosis in children. Curr Opin Hematol. 2005;12:370-6.
33. Franchini M, Lippi G, Manzato F. Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation. Thromb J. 2006;4:4.
34. Okabayashi K, Wada H, Ohta S, Shiku H, Nobori T, Maruyama K. Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit. Am J Hematol. 2004;76:225-9.
35. Angstwurm MW, Dempfle CE, Spannagl M. New disseminated intravascular coagulation score: A useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores. Crit Care Med. 2006;34:314-20.
36. El-Nawawy A, Abbassy AA, El-Bordiny M, Essawi S. Evaluation of early detection and management of disseminated intravascular coagulation among Alexandria University pediatric intensive care patients. J Trop Pediatr. 2004;50:339-47.
37. van der Putten RF, Glatz JF, Hermens WT. Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes. Clin Chim Acta. 2006;371:37-54.
38. Khuseyinova N, Koenig W. Biomarkers of outcome from cardiovascular disease. Curr Opin Crit Care. 2006;12:412-9.
39. Lowe GD. Fibrin D-dimer and cardiovascular risk. Semin Vasc Med. 2005;5:387-98.
40. Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation. 1994;90:2236-40.
41. Lowe GD, Rumley A, Sweetnam PM, Yarnell JW, Rumley J. Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the Caerphilly Study. Thromb Haemost. 2001;86:822-7.
42. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation. 2001;103:2323-7.
43. Rallidis LS, Vikelis M, Panagiotakos DB, Liakos GK, Krania E, Kremastinos DT. Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients. Acta Neurol Scand. 2008;117:415-20.
44. Di Napoli M, Papa F; Villa Pini Stroke Data Bank Investigators. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke. 2002;33:1763-71.
45. McDermott MM, Greenland P, Green D, Guralnik JM, Criqui MH, Liu K, et al. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation. 2003;107:3191-8.
46. Mangiafico RA, Sarnataro F, Mangiafico M, Fiore CE. Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels. Age Ageing. 2006;35:60-5.
47. Musicant SE, Taylor LM Jr, Peters D, Schuff RA, Urankar R, Landry GJ, et al. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease. J Vasc Surg. 2006;43:772-80.
48. Sechi LA, Zingaro L, Catena C, Casaccio D, De Marchi S. Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension. Hypertension. 2000;36:978-85.
49. Lip GY, Blann AD, Edmunds E, Beevers DG. Baseline abnormalities of endothelial function and thrombogenesis in relation to prognosis in essential hypertension. Blood Coagul Fibrinolysis. 2002;13:35-41.
50. Franchini M, Montagnana M, Targher G, Manzato F, Lippi G. Pathogenesis, clinical and laboratory aspects of thrombosis in cancer. J Thromb Thrombolysis. 2007;24:29-38.
51. Tripodi A, Mannucci PM, Chantarangkul V, Bottasso B, Arbini AA, Della Bella S, et al. Markers of procoagulant imbalance in patients with localized melanomas and autoimmune disorders. Br J Haematol. 1993;84:670-4.
52. Lippi G, Franchini M, Biasiutti C, Dellagiacoma G, Salvagno GL, Guidi GC. Increased D-dimer value and occult cancer in the absence of detectable thrombosis. Haematologica. 2007;92:e53-5.
53. Kilic M, Yoldas O, Keskek M, Ertan T, Tez M, Gocmen E, et al. Prognostic value of plasma D-dimer levels in patients with colorectal cancer. Colorectal Dis. 2008;10:238-41.
54. Schutgens RE, Beckers MM, Haas FJ, Biesma DH. The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis. Haematologica. 2005;90:214-9.
55. Kuo JR, Lin KC, Lu CL, Lin HJ, Wang CC, Chang CH. Correlation of a high D-dimer level with poor outcome in traumatic intracranial hemorrhage. Eur J Neurol. 2007;14:1073-8.
56. Akman B, Afsar B, Ataç FB, Ibis A, Arat Z, Sezer S, et al. Predictors of vascular access thrombosis among patients on the cadaveric renal transplantation waiting list. Transplant Proc. 2006;38:413-5.
57. Padden MO. HELLP syndrome: recognition and perinatal management. Am Fam Physician. 1999;60:829-36.
58. Bates SM, Ginsberg JS. Pregnancy and deep vein thrombosis. Semin Vasc Med. 2001;1:97-104.
59. Rogolino A, Coccia ME, Fedi S, Gori AM, Cellai AP, Scarselli GF, et al. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. Blood Coagul Fibrinolysis. 2003;14:277-82.
60. Kubo H, Nakayama K, Yanai M, Suzuki T, Yamaya M, Watanabe M, et al. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest. 2005;128:1475-82.
61. Matsumoto T, Wada H, Nishiyama H, Hirano T, Sakakura M, Nishii K, et al. Hemostatic abnormalities and changes following bone marrow transplantation. Clin Appl Thromb Hemost. 2004;10:341-50.
62. Hocher B, Ziebig R, Altermann C, Krause R, Asmus G, Richter CM, et al. Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis. J Am Soc Nephrol. 2003;14:2329-37.
63. Angstwurm MW, Reininger AJ, Spannagl M. D-dimer as marker for microcirculatory failure: correlation with LOD and APACHE II scores. Thromb Res. 2004;113:353-9.
64. Querol-Ribelles JM, Tenias JM, Grau E, Querol-Borras JM, Climent JL, Gomez E, et al. Plasma D-dimer levels correlate with outcomes in patients with community-acquired pneumonia. Chest. 2004;126:1087-92.
65. Rollin PE, Bausch DG, Sanchez A. Blood chemistry measurements and D-dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis. 2007;196 Suppl 2:S364-71.
66. Palareti G, Legnani C, Cosmi B, Guazzaloca G, Cini M, Mattarozzi S. Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence. J Thromb Haemost. 2005;3:955-61.
67. Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, et al. PROLONG Investigators. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med. 2006;355:1780-9.
68. Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, Tabakoglu E, et al. High plasma D-dimer level is associated with decreased survival in patients with lung cancer. Clin Oncol (R Coll Radiol). 2007;19:494-8.
69. Di Nisio M, Klerk CP, Meijers JC, Büller HR. The prognostic value of the D-dimer test in cancer patients treated with and without low-molecular-weight heparin. J Thromb Haemost. 2005;3:1531-3.
70. Marcucci R, Gori AM, Giannotti F, Baldi M, Verdiani V, Del Pace S, et al. Markers of hypercoagulability and inflammation predict mortality in patients with heart failure. J Thromb Haemost. 2006;4:1017-22.
71. Dempfle CE. Validation, calibration, and specificity of quantitative D-dimer assays. Semin Vasc Med. 2005;5:315-20.
72. Michiels JJ, Gadisseur A, van der Planken M, Schroyens W, De Maeseneer M, Hermsen JT, et al. Different accuracies of rapid enzyme-linked immunosorbent, turbidimetric, and agglutination D-dimer assays for thrombosis exclusion: impact on diagnostic work-ups of outpatients with suspected deep vein thrombosis and pulmonary embolism. Semin Thromb Hemost. 2006;32:678-93.
73. Meijer P, Haverkate F, Kluft C, de Moerloose P, Verbruggen B, Spannagl M. A model for the harmonisation of test results of different quantitative D-dimer methods. Thromb Haemost. 2006;95:567-72.
74. Jennings I, Woods TA, Kitchen DP, Kitchen S, Walker ID. Laboratory D-dimer measurement: improved agreement between methods through calibration. Thromb Haemost. 2007;98:1127-35.
75. Siragusa S. D-dimer testing: advantages and limitations in emergency medicine for managing acute venous thromboembolism. Intern Emerg Med. 2006;1:59-66.
76. Lippi G, Veraldi GF, Fraccaroli M, Manzato F, Cordiano C, Guidi G. Variation of plasma D-dimer following surgery: implications for prediction of postoperative venous thromboembolism. Clin Exp Med. 2001;1:161-4.
77. Kline JA, Williams GW, Hernandez-Nino J. D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed. Clin Chem. 2005;51:825-9.
78. Epiney M, Boehlen F, Boulvain M, Reber G, Antonelli E, Morales M, et al. D-dimer levels during delivery and the postpartum. J Thromb Haemost. 2005;3:268-71.
79. Gillet JL, Ffrench P, Hanss M, Allaert FA, Chleir F. Predictive value of D-dimer assay in superficial thrombophlebitis of the lower limbs. J Mal Vasc. 2007;32:90-5.
80. Spadaro A, Tortorella V, Morace C, Fortiguerra A, Composto P, Bonfiglio C, et al. High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis. World J Gastroenterol. 2008;14:1549-52.
81. Söhne M, Kamphuisen PW, van Mierlo PJ, Büller HR. Diagnostic strategy using a modified clinical decision rule and D-dimer test to rule out pulmonary embolism in elderly in-and outpatients. Thromb Haemost. 2005;94:206-10.